Cancer-related fatigue
Pro Research Analysisby 
Searched over 200M research papers for "cancer-related fatigue"
Prevalence and Impact of Cancer-Related Fatigue
Cancer-related fatigue (CRF) is one of the most common and distressing symptoms experienced by cancer patients, with prevalence rates ranging from 40% to 100% depending on the population and assessment methods used 1348+2 MORE. Meta-analyses estimate that about half of all cancer patients experience CRF, with severe fatigue affecting up to 43% of patients and even higher rates when mild fatigue is included 910. CRF can persist for months or even years after treatment, significantly reducing quality of life by interfering with daily activities, work, social interactions, and relationships 1348.
Defining Cancer-Related Fatigue: Distinct Features
CRF is defined as a distressing, persistent, and subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or its treatment, which is not proportional to recent activity and is not relieved by rest or sleep 124. This distinguishes CRF from normal tiredness, as it is more severe, longer-lasting, and less responsive to typical restorative measures 124.
Risk Factors and Contributing Conditions
Several risk factors increase the likelihood of developing CRF, including poor performance status, undergoing chemoradiotherapy, female sex, insomnia, neuroticism, pain, and depression 910. The prevalence and severity of CRF can also vary by cancer type, treatment phase, and the method of assessment, with self-reported fatigue rates being much higher than those assessed by physicians . Notably, chemotherapy is associated with a higher prevalence of severe CRF compared to surgery or radiotherapy 910.
Pathophysiology and Mechanisms of Cancer-Related Fatigue
The exact biological mechanisms underlying CRF are not fully understood, but it is believed to be multifactorial, involving both central and peripheral processes 5678. Proposed mechanisms include cytokine dysregulation, hypothalamic-pituitary-adrenal axis disruption, circadian rhythm disturbances, neurotransmitter imbalances (such as serotonin), vagal nerve activation, and changes in muscle metabolism and ATP production 5678. Inflammation is thought to play a key role in the development and persistence of CRF, and individual host factors may also contribute .
Assessment and Screening for Cancer-Related Fatigue
Reliable assessment tools are available to measure the severity of CRF, and regular screening is recommended for all cancer patients 347. Early identification is important because CRF is often underreported by patients and underestimated by clinicians, leading to missed opportunities for intervention 34.
Management Strategies: Pharmacologic and Nonpharmacologic Interventions
Management of CRF involves addressing reversible contributing factors such as anemia, sleep disturbances, pain, and emotional distress 347. Both pharmacologic (e.g., psychostimulants, hematopoietic agents for anemia) and nonpharmacologic interventions (e.g., exercise, psycho-educational programs, mind-body therapies like yoga and acupuncture) have shown benefits in randomized controlled trials 2478. Mild fatigue may be managed with nonpharmacologic measures alone, while moderate to severe fatigue may require a combination of approaches 3478.
Barriers to Effective Management
Despite available treatments, CRF is often viewed as an inevitable and untreatable consequence of cancer and its treatment by both patients and healthcare providers, which can hinder effective management 13. Education and routine screening are essential to change this perception and improve patient outcomes 134.
Conclusion
Cancer-related fatigue is a highly prevalent, persistent, and debilitating symptom that significantly impairs quality of life for cancer patients and survivors. Its complex and multifactorial nature requires comprehensive assessment and a combination of management strategies. Increased awareness, regular screening, and proactive intervention are crucial to improving the lives of those affected by CRF 1348+2 MORE.
Sources and full results
Most relevant research papers on this topic